WARRICK 1624 1624
Pill imprint WARRICK 1624 1624 has been identified as Griseofulvin, ultramicrocrystalline ultramicrocrystalline 330 mg.
Griseofulvin is used in the treatment of tinea capitis; tinea cruris; dermatophytosis; tinea corporis; onychomycosis, toenail (and more), and belongs to the drug class miscellaneous antifungals. Risk cannot be ruled out during pregnancy.
Griseofulvin ultramicrocrystalline 330 mg is not subject to the Controlled Substances Act.
See also related documents.
Griseofulvin, ultramicrocrystalline Images
- Imprint:
-
WARRICK
1624 1624 - Strength:
- ultramicrocrystalline 330 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antifungals
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Martec Pharmaceuticals Inc
Advertisement
More Griseofulvin, Ultramicrocrystalline resources
- Griseofulvin Microsize Oral Suspension (Wolters Kluwer)
- Griseofulvin Microsize Tablets (Wolters Kluwer)
- Griseofulvin Ultramicrosize Tablets (Wolters Kluwer)
- griseofulvin (Cerner Multum)
- griseofulvin (Micromedex) - Includes Dosage Information
- Griseofulvin (AHFS DI)
- Griseofulvin (FDA)
Search Again
